Octarine Bio boosts Series A to accelerate sustainable colour platform
Copenhagen-based biotech startup Octarine Bio has secured an additional €5 million to expand its Series A funding round, strengthening its mission to replace synthetic dyes and pigments with sustainable, bio-based colour solutions. The fresh capital will help the company accelerate development and commercialization of its proprietary sustainable colour platform, targeting applications across food, cosmetics, textiles and advanced materials.
A synthetic biology approach to colour
Octarine Bio operates at the intersection of synthetic biology, metabolic engineering and industrial biotechnology. Instead of relying on petrochemical-derived or heavy-metal-based colourants, the company engineers microorganisms to produce high-performance natural pigments at scale.
The startup focuses on biological production of compounds such as flavonoids, carotenoids and other bio-pigments that can deliver vibrant, stable colours while meeting tightening regulatory and sustainability requirements. By programming microbial cell factories, Octarine Bio aims to offer manufacturers a drop-in alternative to conventional synthetic dyes.
Why the colour industry needs disruption
The global colourants market underpins multi-billion-euro industries, from packaged foods and beverages to fashion, cosmetics, plastics and coatings. Yet many legacy pigments are associated with environmental and health concerns, including:
- Dependence on petrochemicals and non-renewable feedstocks
- Use of toxic heavy metals and hazardous intermediates in production
- High CO₂ emissions and water pollution from dye manufacturing
- Mounting regulatory pressure on synthetic additives in food and cosmetics
At the same time, consumer demand for clean-label, plant-based and transparently sourced ingredients is reshaping how brands think about colour. Octarine Bio positions its technology as a way to decouple colour performance from environmental harm, offering bio-based alternatives that can be produced consistently and at industrial scale.
Funding to scale from lab to market
The additional €5 million extension to the Series A round will be used to move Octarine Bio‘s platform from pilot scale to broader commercial deployment. The company plans to invest in:
- Scaling up fermentation and downstream processing capabilities
- Regulatory dossiers for key markets in food, cosmetics and materials
- Partnerships with global FMCG, beauty and textile brands
- Expanding its R&D team in synthetic biology and process engineering in Copenhagen
By extending its Series A, Octarine Bio signals confidence from investors in the commercial viability of its technology and its ability to navigate the demanding safety and performance standards of regulated industries.
Strategic focus on high-value applications
Rather than competing immediately on low-margin commodity dyes, Octarine Bio is expected to focus on high-value segments where performance, safety and sustainability command a premium. These include:
- Food and beverage colourants with enhanced stability and clean-label positioning
- Cosmetic pigments for skincare and makeup, aligned with natural and vegan claims
- Functional materials where colour is linked to UV protection, antioxidant activity or bioactivity
This strategy allows the company to demonstrate the advantages of its platform—such as batch-to-batch consistency, custom shades and tailored functionalities—before expanding to higher-volume segments like textiles and packaging inks.
Positioning Denmark as a bio-innovation hub
The new funding underscores Denmark’s growing role as a European centre for industrial biotech and bio-based materials. With a strong legacy in enzyme production and fermentation, the country offers a deep talent pool, advanced infrastructure and supportive regulation for bioeconomy ventures.
Octarine Bio contributes to this ecosystem by developing platform technologies that can be extended beyond colour. Its engineering capabilities around microbial production of complex molecules could, over time, be applied to flavours, fragrances or other high-value ingredients.
Aligning with ESG and corporate sustainability goals
Global brands are under intense pressure to reduce their environmental footprint and improve transparency across supply chains. Scope 3 emissions, chemical safety and resource efficiency are now board-level issues. By offering bio-based colourants with a potentially lower carbon footprint and more traceable production, Octarine Bio aims to become a strategic partner for companies pursuing ambitious ESG targets.
For manufacturers, switching to biologically produced pigments could support multiple sustainability metrics at once: reduced reliance on fossil resources, lower toxic by-products and better alignment with circular-economy principles.
Challenges ahead for bio-based colour
Despite the momentum, scaling a synthetic biology platform into a mainstream industrial solution is complex. Octarine Bio will need to prove that its colours can match or exceed the performance of synthetic incumbents on crucial parameters such as:
- Colour intensity and shade reproducibility
- Stability under heat, light and processing conditions
- Cost competitiveness at commercial volumes
- Regulatory compliance across multiple jurisdictions
Furthermore, the company must build robust supply chains and partnerships with contract manufacturers and brand owners, while navigating a competitive landscape that includes both traditional natural colour suppliers and emerging synbio players.
What the extended Series A means for the market
The €5 million top-up to Octarine Bio‘s Series A round is more than a capital injection; it is a signal to the broader market that bio-based colour technologies are moving from research promise to commercial reality. As brands search for credible alternatives to synthetic dyes, platforms that can deliver both sustainability and performance are likely to gain significant traction.
For the European tech and biotech ecosystem, the deal reinforces the region’s competitive edge in climate-tech and green chemistry. For investors, it highlights an emerging category where regulatory shifts, consumer preferences and technological breakthroughs are converging to create new market leaders.
As Octarine Bio deploys its expanded Series A funding, the coming years will be critical in determining how quickly sustainable, fermentation-derived colours can penetrate mainstream products—and how fast the legacy colour industry will be forced to adapt.